Pure Global

Can unscheduled inpatient length of stay and hospital costs be reduced using 'flash' glucose monitoring? - Trial ISRCTN11565460

Access comprehensive clinical trial information for ISRCTN11565460 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of the Highlands and Islands and is currently status unknown. The study focuses on Diabetes mellitus. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
ISRCTN11565460
Phase 2
Device Trial
device
Trial Details
ISRCTN Registry โ€ข ISRCTN11565460
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Can unscheduled inpatient length of stay and hospital costs be reduced using 'flash' glucose monitoring?
Interreg diabetes centre for personalised medicine - unscheduled care in diabetes - study 2: inpatient study

Study Focus

Diabetes mellitus

Flash Glucose Monitoring

Interventional

device

Sponsor & Location

University of the Highlands and Islands

Interreg

Ireland,United Kingdom

Timeline & Enrollment

Phase 2

Oct 14, 2019

Jan 31, 2022

60 participants

Summary

Can unscheduled inpatient length of stay and hospital costs be reduced using โ€˜Flashโ€™ glucose monitoring?

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Unspecified diabetes mellitus with unspecified complications

Data Source

ISRCTN Registry

ISRCTN11565460

Device Trial